Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
>CME/CNE ARTICLE: Severity Grading in Multiple Sclerosis: A Proposal.
The Dress: Transforming a web viral event into a scientific survey.
Neurofilament light in CSF and serum is a sensitive marker for axonal white matter injury in MS.
Characterizing axonal myelination within the healthy population: a tract-by-tract mapping of effects of age and gender on the fiber g-ratio.
Regional disparities in botulinum toxin A (BoNT-A) therapy for spasticity in Sweden: budgetary consequences of closing the estimated treatment gap.
Regulation of PERK-eIF2α signalling by tuberous sclerosis complex-1 controls homoeostasis and survival of myelinating oligodendrocytes.
An attenuated immune response by Schwann cells and macrophages inhibits nerve regeneration in aged rats.
Tamoxifen accelerates the repair of demyelinated lesions in the central nervous system.
Interleukin 2 activates brain microvascular endothelial cells resulting in destabilization of adherens junctions.
Atypical presentations of acute disseminated encephalomyelitis (ADEM) in HIV infection.
Impaired oligodendroglial turnover is associated with myelin pathology in Focal Cortical Dysplasia and Tuberous Sclerosis Complex.
Normal-appearing brain tissue analysis in radiologically isolated syndrome using 3 T MRI.
Tear fluid biomarkers in ocular and systemic disease: potential use for predictive, preventive and personalised medicine.
Recurrent myelopathy and optic neuritis associated with systemic lupus erythematosus.
A pediatric patient of hemorrhagic acute transverse myelitis.
Safety and efficacy of amiselimod in relapsing multiple sclerosis (MOMENTUM): a randomised, double-blind, placebo-controlled phase 2 trial.
Gait Disturbance as the Presenting Symptom in Young Children With Anti-NMDA Receptor Encephalitis.
Poster 463 Unexpected Transverse Myelitis after Dinutuximab Therapy for Relapsed Neuroblastoma: A Case Report.
Cutaneous and Mixed Nerve Silent Period Recordings in Symptomatic Paroxysmal Kinesigenic Dyskinesia.
Diffusion tensor imaging predicts cognitive function change following partial brain radiotherapy for low-grade and benign tumors.
Multiple Sclerosis Patients Valuing Their Own Health Status: Valuation and Psychometric Properties of the 15D.
Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy.
Cognitive impairment among patients with multiple sclerosis: associations with employment and quality of life.
Price Analysis of Multiple Sclerosis Disease-Modifying Therapies Marketed in the United States.
Pages
« first
‹ previous
…
805
806
807
808
809
810
811
812
813
next ›
last »